Israeli technology firm BioHarvest Sciences claims to have cracked the cell tissue production code as it brings the first fruits of its labor to market — a resveratrol-heavy offering made from cells taken from the skin of red grapes. Cannabinoids...
CarryOn is a new line of CBD sparkling waters developed by Ocean Spray’s Lighthouse Incubator. CarryOn’s Managing Director, Christopher Petersen, joined the NutraCast to discuss the innovation Incubator and explain how he went from being an army officer...
A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.
The advent of a strategic patent has put formulation specialist Biomedican on course to fundamentally alter the cannabinoid supply picture, the company claims. In addition, a Mexican court ruling has opened up opportunities south of the border.
More and more companies are using apps to gain insights on their respective industries. With the right data inputs, technology can improve decision making and help company leaders zero in on trends. The Releaf App is one such application that individuals...
The publication of a recent FDA priorities list that omitted the hemp/CBD question is a reminder that a legislative solution is the only practical way forward for a regulatory resolution for these ingredients, advocates say.
Months ago, many may not have even been aware of the existence of this cannabis compound. Today, Delta-8 is the fastest-growing category of hemp products, with US sales of products listing Delta-8 jumping 144% from a year earlier, according to cannabis...
Ayurveda is an ancient eastern medical practice that’s been around over 5 thousand years. And while CBD isn’t anything new, modern medicine has only recently began conducting research.
The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.
The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...
Royal DSM has entered into a broad commercial partnership with Colorado-based cannabinoid company Mile High Labs (MHL) for next generation science-backed cannabinoid solutions.
Despite a pessimistic outlook for the state of the CBD market, the CEO of a leading brand said there’s plenty of opportunity for companies committed to doing things the right way.
With US retail sales of cannabidiol-infused foods, beverages and supplements declining sharply in the past year and some early-adopters souring on the ingredient after experiencing lackluster ‘results,’ some players in the space are discontinuing their...
Contract research organization KGK Science Inc. will be acquired by Canadian investment issuer Myconic Capital Corp., it was announced yesterday. The deal is valued at as much as $16.5 million.
A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.
A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.
Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.
In a sign of further consolidation within the CBD/hemp products industry, THC Farmaceuticals Inc has announced it has acquired a contract manufacturer in Southern California.
Many of us know that valerian root, ashwagandha, chamomile and melatonin are helpful in delivering a good night’s rest. But how about CBN? Stuart Titus, PhD, CEO and president at Medical Marijuana, said that cannabinol hasn't really been available...
Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry to speak with a united voice”, says Loren Israelsen, President of the United Natural Products...
A report from a watchdog group found found that just 42% of CBD brands tested all their products for potency. Additionally, the vast majority of products tested were outside the limits of acceptable variance.
While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”
The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...
Fish oils supplier KD Pharma has moved more aggressively into the cannabinoid space with the acquisition of the manufacturing assets of a Swiss CBD and phyotextract specialist firm, the company announced today.
Two professional rugby players have created a startup selling third-party tested CBD supplements that give elite athletes and everyday consumers peace of mind over cannabinoid content
HempFusion, a manufacturer of CBD-containing ingestible and topical products, said a successful initial public offering and a refocus of its digital sales efforts will position the brand to become one of the major hemp/CBD players in 2021.
Texas delivery technology development firm Santé Laboratories is opening up its cannabinoid delivery system to brand holders. The approach has been validated with a direct to consumer control brand called RESET Bioscience.
Imagine taking the time and effort to cultivate hemp across hundreds of acres, only to find out that your harvest is contaminated. The damage can cause an odor, spoilage or significant illness to the end user if left unchecked.
Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.
Before her foray into the botanical wellness industry, Amanda Jones spent two decades traveling the world as a journalist for Vogue Magazine. While it may sound like a luxurious position, Jones' work also put her up close and personal with women...
From respiratory support to superfoods, oral health to UTI defense, March showed up and showed out with supplements for just about anything the year throws at you.
The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...
The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...
Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.
A UK-based CBD and hemp supplier has inked a deal with a prominent mixed martial arts organization, a move that underscores fighters and MMA organizations normalizing and embracing the use of CBD.
Folium Biosciences has become another US-based firm to submit a Novel Foods application to the UK for its cannabidiol (CBD)-based oil in response to the 31 March deadline set by the country’s food authority.
The FSA (Food Standards Agency) has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving...
